GPT and metabolic dysfunction-associated steatotic liver disease: Based on the results we had found, it would greatly increase the number of asymptomatic patients with abnormal ALT values–in China alone, by many millions of patients each year, and would identify more patients with NAFLD and clinically mild HBV infection.